Cargando…
Newer antithrombotic drugs
Thromboembolic disorders are one of the disorders for which we are still on the look out for a safe and efficient drug. Despite the widespread use of antithrombotic drugs for the prevention and treatment of arterial and venous thrombosis, thromboembolic diseases continue to be a major cause of death...
Autores principales: | Sikka, Pranav, Bindra, V. K. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3085220/ https://www.ncbi.nlm.nih.gov/pubmed/21572750 http://dx.doi.org/10.4103/0972-5229.76083 |
Ejemplares similares
-
Long-Term Anticoagulation in the Extreme Elderly with the Newer Antithrombotics: Safe or Sorry?
por: Chiong, Jun R, et al.
Publicado: (2013) -
In the Quest of Drugs for Bad Bugs: Are Newer Fluoroquinolones Any Better?
por: Deep, Antariksh, et al.
Publicado: (2011) -
Iptakalim: A novel multi-utility potassium channel opener
por: Sikka, Pranav, et al.
Publicado: (2012) -
Atrial fibrillation and percutaneous coronary intervention: Are newer antithrombotic agents better for older patients?
por: Leggio, Massimo, et al.
Publicado: (2018) -
Drug resistance in leishmaniasis: Newer developments
por: Mohapatra, Sarita
Publicado: (2014)